funder-graph › Recipients
Who funds Odylia Therapeutics Inc
EIN 82-2120760 · Atlanta, GA · NTEE H41
Odylia Therapeutics Inc of Atlanta, GA (EIN 82-2120760) was named as a grant recipient by 11 funders in 24 grants paid totaling $2,948,422 in tax years 2020–2025, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.
Grants received
$2,948,422
24 grants paid
Funders
11
distinct grantmakers
Tax years
2020–2025
as reported by funders
Funders
| Funder | State | Match | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| The Foundation Fighting Blindness Inc 23-7135845 | MD | A | 2 | $1,500,000 | 2025 |
| Usher 2020 Foundation Inc 46-1440524 | GA | A | 4 | $601,943 | 2024 |
| Marin Community Foundation 94-3007979 | CA | A | 1 | $500,000 | 2022 |
| National Philanthropic Trust 23-7825575 | PA | A | 3 | $90,000 | 2025 |
| The Dorfman Foundation Inc 80-0966164 | GA | C | 2 | $68,000 | 2023 |
| Morgan Stanley Global Impact Funding Trust Inc 52-7082731 | IN | A | 3 | $52,500 | 2024 |
| Rdh12 Fund for Sight 45-4028932 | SC | A | 1 | $50,000 | 2021 |
| Michael Chernow Trust Fbo Charity Ccc 13-6758226 | NY | C | 2 | $50,000 | 2024 |
| Donor Advised Charitable Giving Inc 31-1640316 | CO | A | 1 | $25,000 | 2025 |
| American Online Giving Foundation Inc 81-0739440 | DE | A | 2 | $10,236 | 2025 |
| Amazonsmile Foundation 46-2626883 | WA | C | 3 | $743 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Grants
The 24 most recent grants naming this organization.
| Tax year | Funder | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|---|
| 2025 | The Foundation Fighting Blindness Inc | Odylia Therapeutics Atlanta, GA | A | $631,039 | paid | RESEARCH | 202503079349303810 |
| 2025 | National Philanthropic Trust | Odylia Therapeutics Inc Atlanta, GA | A | $40,000 | paid | EDUCATION | 202601289349302480 |
| 2025 | Donor Advised Charitable Giving Inc | Odylia Therapeutics Inc Atlanta, GA | A | $25,000 | paid | HEALTH | 202611199349300601 |
| 2025 | American Online Giving Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $5,118 | paid | GENERAL SUPPORT | 202533509349301608 |
| 2025 | American Online Giving Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $5,118 | paid | GENERAL SUPPORT | 202641969349302754 |
| 2024 | The Foundation Fighting Blindness Inc | Odylia Therapeutics Atlanta, GA | A | $868,961 | paid | RESEARCH | 202433129349301503 |
| 2024 | Usher 2020 Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $212,502 | paid | RESEARCH FOR PREVENTION OF USHER SYNDROME BLINDNESS. | 202523219349302402 |
| 2024 | Morgan Stanley Global Impact Funding Trust Inc | Odylia Therapeutics Atlanta, GA | A | $35,000 | paid | UNRESTRICTED GENERAL SUPPORT | 202503239349300435 |
| 2024 | Michael Chernow Trust Fbo Charity Ccc | Odylia Therapeutics Atlanta, GA | C | $25,000 | paid | GEN'L CHARITABLE | 202413139349101401 |
| 2023 | Usher 2020 Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $193,089 | paid | RESEARCH FOR PREVENTION OF USHER SYNDROME BLINDNESS. | 202423309349300222 |
| 2023 | The Dorfman Foundation Inc | Odylia Therapeutics Atlanta, GA | C | $40,000 | paid | TO HELP SUPPORT ODYLIA THERAPEUTICS | 202413359349100801 |
| 2023 | Michael Chernow Trust Fbo Charity Ccc | Odylia Therapeutics Atlanta, GA | C | $25,000 | paid | Gen'l Charitable | 202302569349100230 |
| 2023 | National Philanthropic Trust | Odylia Therapeutics Inc Atlanta, GA | A | $25,000 | paid | HEALTH | 202431429349301368 |
| 2023 | Morgan Stanley Global Impact Funding Trust Inc | Odylia Therapeutics Atlanta, GA | A | $10,000 | paid | UNRESTRICTED GENERAL SUPPORT | 202403209349313980 |
| 2023 | Amazonsmile Foundation | Odylia Therapeutics Inc Atlanta, GA | C | $294 | paid | GENERAL SUPPORT | 202540919349100629 |
| 2022 | Marin Community Foundation | Odylia Therapeutics Inc Atlanta, GA | A | $500,000 | paid | PROGRAM SUPPORT | 202321329349307422 |
| 2022 | Usher 2020 Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $133,283 | paid | RESEARCH FOR PREVENTION OF USHER SYNDROME BLINDNESS. | 202313199349314396 |
| 2022 | The Dorfman Foundation Inc | Odylia Therapeutics Atlanta, GA | C | $28,000 | paid | TO HELP SUPPORT ODYLIA THERAPEUTICS | 202313139349100716 |
| 2022 | National Philanthropic Trust | Odylia Therapeutics Inc Atlanta, GA | A | $25,000 | paid | HEALTH | 202311359349313966 |
| 2022 | Morgan Stanley Global Impact Funding Trust Inc | Odylia Therapeutics Atlanta, GA | A | $7,500 | paid | UNRESTRICTED GENERAL SUPPORT | 202302999349301010 |
| 2022 | Amazonsmile Foundation | Odylia Therapeutics Inc Atlanta, GA | C | $413 | paid | GENERAL SUPPORT | 202313119349100141 |
| 2021 | Rdh12 Fund for Sight | Odylia Therapeutics Atlanta, GA | A | $50,000 | paid | RESEARCH GRANT | 202300269349300110 |
| 2020 | Usher 2020 Foundation Inc | Odylia Therapeutics Inc Atlanta, GA | A | $63,069 | paid | RESEARCH FOR PREVENTION OF USHER SYNDROME BLINDNESS. | 202113199349304496 |
| 2020 | Amazonsmile Foundation | Odylia Therapeutics Inc Atlanta, GA | C | $36 | paid | GENERAL SUPPORT | 202113199349100901 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.